Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 6/20 | 0.48 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.33 |
| ▸ | ITGB1 | P05556 | 2/20 | 0.33 |
| ▸ | ITGAV | P06756 | 2/20 | 0.33 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.33 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.33 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.33 |
| ▸ | ITGB5 | P18084 | 1/20 | 0.33 |
| ▸ | ITGAL | P20701 | 1/20 | 0.33 |
| ▸ | DDB1 | Q16531 | 3/20 | 0.31 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Succinimide SCHEMBL30823560 | 0.93 | CRBN (0.55) | CRBNFFAR3KDM4ELMNACYP2C19 | |
| Succinimide SCHEMBL2221415 | 0.93 | CRBN (0.55) | CRBNFFAR3KDM4ELMNACYP2C19 | |
| Succinimide SCHEMBL28348066 | 0.86 | CRBN (0.52) | CRBNFFAR3KDM4ELMNACYP2C19 | |
| Succinimide SCHEMBL29278585 | 0.86 | CRBN (0.52) | CRBNFFAR3KDM4ELMNACYP2C19 | |
| Succinimide SCHEMBL20786978 | 0.86 | CRBN (0.58) | CRBNKDM4ELMNACYP2C19ITGB3 | |
| Succinimide SCHEMBL6153012 | 0.86 | CRBN (0.58) | CRBNKDM4ELMNACYP2C19ITGB3 | |
| Succinimide SCHEMBL28398892 | 0.86 | FFAR3 (0.50) | CRBNFFAR3 | |
| Succinic Acid SCHEMBL28918359 | 0.84 | CRBN (0.50) | CRBNKDM4ELMNAITGB3ITGB1 | |
| Succinic Acid SCHEMBL27856042 | 0.84 | CRBN (0.50) | CRBNKDM4ELMNAITGB3ITGB1 | |
| Succinimide SCHEMBL29132313 | 0.84 | CRBN (0.55) | CRBNKDM4ELMNACYP2C19ITGB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023088272-A1 | UNDERGLYCOSYLATED KALLIKREIN I, AND POLYETHYLENE GLYCOL MODIFIER THEREOF AND PHARMACEUTICAL USE THEREOF | 江苏众红生物工程创药研究院有限公司 | 2023-05-25 | — | — | WO | claimed |
| CN-115919755-A | Low-concentration hydrogel and preparation method and application thereof | 沈阳药科大学 | 2023-04-07 | — | — | CN | claimed |
| CN-110201234-B | Prostate cell microcapsule for tissue engineering and preparation method thereof | 山东百多安医疗器械股份有限公司 | 2021-09-03 | — | — | CN | claimed |
| CN-110251731-B | Islet cell microcapsule for tissue engineering and preparation method thereof | 山东百多安医疗器械股份有限公司 | 2021-09-03 | — | — | CN | claimed |
| CN-112023122-A | In-situ injection jelly as well as preparation method and application thereof | 北京爱特康医疗科技有限公司 | 2020-12-04 | — | — | CN | claimed |
| WO-2023143256-A1 | USE OF KININ OR DERIVATIVE THEREOF IN TREATING VCI, PSCI, OR CSVD | 江苏众红生物工程创药研究院有限公司 | 2023-08-03 | — | — | WO | disclosed |
| WO-2023143246-A1 | POLYETHYLENE GLYCOL-MODIFIED FORM OF KININ OR DERIVATIVE THEREOF AND PHARMACEUTICAL USE THEREOF | 江苏众红生物工程创药研究院有限公司 | 2023-08-03 | — | — | WO | disclosed |
| WO-2023088272-A1 | UNDERGLYCOSYLATED KALLIKREIN I, AND POLYETHYLENE GLYCOL MODIFIER THEREOF AND PHARMACEUTICAL USE THEREOF | 江苏众红生物工程创药研究院有限公司 | 2023-05-25 | — | — | WO | disclosed |
| CN-115919755-A | Low-concentration hydrogel and preparation method and application thereof | 沈阳药科大学 | 2023-04-07 | — | — | CN | disclosed |
| CN-111773178-B | Hydrogel lacrimal passage suppository and preparation method thereof | 北京诺康达医药科技股份有限公司 | 2022-11-25 | — | — | CN | disclosed |
| CN-109963597-B | Pegylated endostatin analogs and uses thereof | 北京普罗吉生物科技发展有限公司 | 2022-08-26 | — | — | CN | disclosed |
| CN-110643057-B | Application of polyethylene glycol activated ester in preparation of low-swelling hydrogel and low-swelling hydrogel comprising polyethylene glycol activated ester | 赛克赛斯生物科技股份有限公司 | 2022-05-17 | — | — | CN | disclosed |
| CN-112023122-B | In-situ injection jelly as well as preparation method and application thereof | 北京爱特康医疗科技有限公司 | 2021-03-19 | — | — | CN | disclosed |
| CN-109077993-B | Lacrimal duct slow-release hydrogel implant and preparation method thereof | 北京诺康达医药科技股份有限公司 | 2021-03-16 | — | — | CN | disclosed |
| CN-112023122-A | In-situ injection jelly as well as preparation method and application thereof | 北京爱特康医疗科技有限公司 | 2020-12-04 | — | — | CN | disclosed |
| CN-107760661-B | PEG modifier of medicinal kininogenase and preparation method and application thereof | 江苏众红生物工程创药研究院有限公司 | 2020-10-27 | — | — | CN | disclosed |
| CN-111773178-A | Hydrogel lacrimal passage suppository and preparation method thereof | 北京诺康达医药科技股份有限公司 | 2020-10-16 | — | — | CN | disclosed |
| CN-111182926-A | Particles comprising bilirubin derivatives and metals | 株式会社毕丽斯 | 2020-05-19 | — | — | CN | disclosed |
| CN-110643057-A | Application of polyethylene glycol activated ester in preparation of low-swelling hydrogel and low-swelling hydrogel comprising same | 赛克赛斯生物科技股份有限公司 | 2020-01-03 | — | — | CN | disclosed |
| CN-103881084-A | Phospholipid derivative of branched polyethylene glycol and lipid membrane structure body composed of phospholipid derivative | XIAMEN SINOPEG BIOTECH INC | 2014-06-25 | — | — | CN | disclosed |